Pulmonary Thromboembolism Following Radio-Frequency Ablation of the Atrioventricular Node in a Patient Heterozygous for the Factor V Leiden and the Mthfr C677T Mutations

Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008; 358(10): 1037-1052.10.1056/NEJMra072753Search in Google Scholar

Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematol Am Soc Hematol Educ Program. 2005:1-12.10.1182/asheducation.V2005.1.1.1Search in Google Scholar

Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85(6): 1504-1508.10.1182/blood.V85.6.1504.bloodjournal8561504Search in Google Scholar

Zöller B, García de Frutos P, Hillarp A, Dahlbäck B. Thrombophilia as a multigenic disease. Haematologica. 1999; 84(1):59-70.Search in Google Scholar

Djordjevic V, Rakicevic L, Gagic M, Nikolic A, Savic A. Simultaneous detection of factor V Leiden and factor II G20210A variants by a multiplex PCR on whole blood. Balkan J Med Genet. 2001; 4(1&2): 15-17.Search in Google Scholar

Djordjevic V, Stankovic M, Nikolic A, Antonijevic N, Rakicevic LJ, Divac A, Radojkovic M. PCR amplification on whole blood samples treated with different commonly used anticoagulants. Pediatr Hematol Oncol. 2006; 23(6): 517-521.10.1080/08880010600751900Search in Google Scholar

Koebe J, Kirchhof P. Novel non-pharmacological approaches for antiarrhythmic therapy of atrial fibrillation. Europace. 2008; 10(4): 433-437.10.1093/europace/eun058Search in Google Scholar

Papagiannis J, Papadopoulou K, Rammos S, Demosthenes Katritsis D. Cryoablation versus radiofrequency ablation for atrioventricular nodal reentrant tachycardia in children: long-term results. Hellenic J Cardiol. 2010; 51(2): 122-126.Search in Google Scholar

Lin JL, Stephen Huang SK, Lai LP, Ko WC, Tseng YZ, Lien WP. Clinical and electrophysiologic characteristics and long-term efficacy of slow-pathway catheter ablation in patients with spontaneous supraventricular tachycardia and dual atrioventricular node pathways without inducible tachycardia. J Am Coll Cardiol. 1998; 31(4): 855-860.10.1016/S0735-1097(98)00015-1Search in Google Scholar

O'Hara GE, Philippon F, Champagne J, Blier L, Molin F, Côté JM, Nault I, Sarrazin JF, Gilbert M. Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital. Can J Cardiol. 2007; 23(Suppl B): 67B-70B. (Erratum: Can J Cardiol. 2009; 25(3): 140.)10.1016/S0828-282X(07)71013-9Search in Google Scholar

Mansourati J, Deharo JC, Graux P, Chappuis L, Durieu C, Dutoit A, Guillo P, Djiane P, Blanc JJ. Short and medium-term outcome after radiofrequency ablation of the atrioventricular junction. Arch Mal Coeur Vaiss. 1997; 90(7): 945-951. [Article in French]Search in Google Scholar

Darpö B, Walfridsson H, Aunes M, Bergfeldt L, Edvardsson N, Linde C, Lurje L, van der Linden M, Rosenqvist M. Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation. Am J Cardiol. 1997; 80(9): 1174-1177.10.1016/S0002-9149(97)00635-8Search in Google Scholar

Haman L, Parízek P, Alý R, Duda J, Malý J. Analysis of thrombotic complications after catheter ablation. Acta Medica (Hradec Kralove). 2006; 49(1): 47-50.10.14712/18059694.2017.109Search in Google Scholar

Aznar J, Vaya A, Estelles A, Mira Y, Segui R, Villa P, Ferrando F, Falco C, Corella D, Espana F. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica. 2000; 85(12): 1271-1276.Search in Google Scholar

Coen D, Zadro R, Honovic L, Banfic L, Stavljenic Rukavina A. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism. Croat Med J. 2001; 42(4): 488-492.Search in Google Scholar

Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to a poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993; 342(8886-8887): 1503-1506.10.1016/S0140-6736(05)80081-9Search in Google Scholar

Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol. 1999; 19(3): 511-518.10.1161/01.ATV.19.3.51110073951Search in Google Scholar

Mandala M, Curigliano G, Bucciarelli P, Ferretti G, Mannucci PM, Colleoni M, Ventura A, Peruzzotti G, Severi G, Pelicci PG, Biffi R, Orsi F, Cinieri S, Goldhirsch A. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Ann Oncol. 2004; 15(4): 590-593.10.1093/annonc/mdh14615033664Search in Google Scholar

Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis. 2005; 19(3): 189-196.10.1007/s11239-005-1313-x16082606Search in Google Scholar

Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost. 1997; 78(6): 1426-1429.10.1055/s-0038-1665427Search in Google Scholar

Howard TE, Marusa M, Boisza J, Young A, Sequeira J, Channell C, Guy C, Benson E, Duncan A. The prothrombin gene 3'-untranslated region mutation is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency. Blood. 1998; 91(3):1092-1093.10.1182/blood.V91.3.1092Search in Google Scholar

Cattaneo M, Tsai MY, Bucciarelli P, Taioli E, Zighetti ML, Bignell M, Mannucci PM. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep vein thrombosis in patients with mutant factor V (factor V:Q⁵⁰⁶). Arterioscler Thromb Vasc Biol. 1997; 17(9): 1662-1666.10.1161/01.ATV.17.9.1662Search in Google Scholar

Nagorni-Obradovic Lj, Miljic P, Djordjevic V, Pesut D, Jovanovic D, Stojsic J, Stevic R, Radojkovic D. The prothrombin factor II G20210A mutation with pulmonary thromboembolism and a normal level of fibrin degradating products. Balkan J Med Genet. 2009; 12(2): 69-76.10.2478/v10034-010-0007-7Search in Google Scholar

Yamamoto T, Ito M, Nagata S, Suzuki H, Tagawa A, Nagase M, Hishida AJ. Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy. J Rheumatol. 2000; 27(8): 2035-2037.Search in Google Scholar